Correlates of injecting paraphernalia sharing among male drug injectors in Kermanshah, Iran: implications for HCV prevention

References

• Abadie, R., Welch-Lazoritz, M., Gelpi-Acosta, C., Reyes, J. C., & Dombrowski, K. (2016). Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduction Journal, 13, 10. doi:10.1186/s12954-016-0099-9
   PubMed Web of Science ®Google Scholar
• Aceijas, C., & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy, 18, 352–358. doi:10.1016/j.drugpo.2007.04.004
   PubMed Web of Science ®Google Scholar
• Aceijas, C., Stimson, G. V., Hickman, M., & Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. Aids, 18, 2295–2303. doi:10.1097/00002030-200411190-00010
   PubMed Web of Science ®Google Scholar
• Alavi, S. M., & Etemadi, A. (2007). HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pakistan Journal of Medical Sciences, 23, 510.
   Web of Science ®Google Scholar
• Alavian, S., & Fallahian, F. (2009). Epidemiology of hepatitis C in Iran and the world. Shiraz E Medical Journal, 10, 162–172.
   Google Scholar
• Alizadeh, A. H. M., Alavian, S. M., Jafari, K., & Yazdi, N. (2005). Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan-Iran. World Journal of Gastroenterology: WJG, 11, 4085. doi:10.3748/wjg.v11.i26.4085
   PubMed Web of Science ®Google Scholar
• Alter, M. J., Kruszon-Moran, D., Nainan, O. V., Mcquillan, G. M., Gao, F., Moyer, L. A., … Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556–562. doi:10.1056/NEJM199908193410802
   PubMed Web of Science ®Google Scholar
• Amin-Esmaeili, M., Rahimi-Movaghar, A., Razaghi, E., Razaghi, E. M., Baghestani, A., Baghestani, A. R., & Jafari, S. (2012). Factors correlated with hepatitis C and B virus infections among injecting drug users in Tehran, IR Iran. Hepatitis Monthly, 12, 23–31. doi:10.5812/hepatmon.4332
   PubMed Web of Science ®Google Scholar
• Amiri, Z. M., Rezvani, M., Shakib, R. J., & SHAKIB, A. J. (2007). Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province. Plant Disease.
   Google Scholar
• Bialek, S. R., & Terrault, N. A. (2006). The changing epidemiology and natural history of hepatitis C virus infection. Clinics in Liver Disease, 10, 697–715. doi:10.1016/j.cld.2006.08.003
   PubMedGoogle Scholar
• Coates, T. J., Richter, L., & Caceres, C. (2008). Behavioural strategies to reduce HIV transmission: How to make them work better. The Lancet, 372, 669–684. doi:10.1016/S0140-6736(08)60886-7
   PubMed Web of Science ®Google Scholar
• Corson, S., Greenhalgh, D., Taylor, A., Palmateer, N., Goldberg, D., & Hutchinson, S. (2013). Modelling the prevalence of HCV amongst people who inject drugs: An investigation into the risks associated with injecting paraphernalia sharing. Drug and Alcohol Dependence, 133, 172–179. doi:10.1016/j.drugalcdep.2013.05.014
   PubMed Web of Science ®Google Scholar
• Crofts, N., Caruana, S., Bowden, S., & Kerger, M. (2000). Minimising harm from hepatitis C virus needs better strategies. BMJ, 321, 899. doi:10.1136/bmj.321.7265.899
   PubMedGoogle Scholar
• De, P., Roy, E., Boivin, J. F., COX, J., & Morissette, C. (2008). Risk of hepatitis C virus transmission through drug preparation equipment: A systematic and methodological review. Journal of Viral Hepatitis, 15, 279–292. doi:10.1111/j.1365-2893.2007.00942.x
   PubMed Web of Science ®Google Scholar
• Esmaeili, A., Mirzazadeh, A., Carter, G., Hajarizadeh, B., Sacks, H., & Page, K. (2016). Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta‐analysis. Journal of Viral Hepatitis, 24(2), 117–127. doi:10.1111/jvh.12628
   PubMed Web of Science ®Google Scholar
• Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42.
   PubMed Web of Science ®Google Scholar
• Kheirandish, P., Seyedalinaghi, S., Jahani, M., Shirzad, H., Ahmadian, M. S., Majidi, A., … Mcfarland, W. (2009). Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. Journal of Urban Health, 86, 902–908. doi:10.1007/s11524-009-9393-0
   PubMed Web of Science ®Google Scholar
• Latkin, C. A., Buchanan, A. S., Metsch, L. R., Knight, K., Latka, M. H., Mizuno, Y., … Team, I. (2008). Predictors of sharing injection equipment by HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes, (1999), 49, 447. doi:10.1097/QAI.0b013e31818a6546
   PubMed Web of Science ®Google Scholar
• Malekinejad, M., Navadeh, S., Lotfizadeh, A., Rahimi-Movaghar, A., Amin-Esmaeili, M., & Noroozi, A. (2015). High hepatitis C virus prevalence among drug users in Iran: Systematic review and meta-analysis of epidemiological evidence (2001–2012). International Journal of Infectious Diseases, 40, 116–130. doi:10.1016/j.ijid.2015.09.022
   PubMed Web of Science ®Google Scholar
• Mirahmadizadeh, A. R., Majdzadeh, R., Mohammad, K., & Forouzanfar, M. (2009). Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iranian Red Crescent Medical Journal, 11, 325.
   Web of Science ®Google Scholar
• Mirzazadeh, A., Ahmad Hajebi, M., & Saman Zamani, M. (2015, Summer-Autumn). Client-level coverage of needle and syringe program and high-risk injection behaviors: A case study of people who inject drugs in Kermanshah, Iran. Addict Health, 7(3–4), 164–173.
   PubMedGoogle Scholar
• Ng, M. H., Chou, J. Y., Chang, T. J., Lee, P. C., Shao, W. C., Lin, T. Y., … Gossop, M. (2013). High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Addictive Behaviors, 38, 2089–2093. doi:10.1016/j.addbeh.2013.01.010
   PubMed Web of Science ®Google Scholar
• Nokhodian, Z., Meshkati, M., Adibi, P., Ataei, B., Kassaian, N., Yaran, M., … Hassannejad, R. (2012). Hepatitis C among intravenous drug users in Isfahan, Iran: A study of seroprevalence and risk factors. International Journal of Preventive Medicine, 3(Suppl1), S131–S138.
   Google Scholar
• Palmateer, N., Hutchinson, S., Mcallister, G., Munro, A., Cameron, S., Goldberg, D., & Taylor, A. (2014). Risk of transmission associated with sharing drug injecting paraphernalia: Analysis of recent hepatitis C virus (HCV) infection using cross‐sectional survey data. Journal of Viral Hepatitis, 21, 25–32. doi:10.1111/jvh.12117
   PubMed Web of Science ®Google Scholar
• Poudel, K. C., Poudel-Tandukar, K., Yasuoka, J., Joshi, A. B., & JIMBA, M. (2010). Correlates of sharing injection equipment among male injecting drug users in Kathmandu, Nepal. International Journal of Drug Policy, 21, 507–510. doi:10.1016/j.drugpo.2010.03.006
   PubMed Web of Science ®Google Scholar
• Pouget, E. R., Hagan, H., & Des Jarlais, D. C. (2012). Meta‐analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction, 107, 1057–1065. doi:10.1111/add.2012.107.issue-6
   PubMed Web of Science ®Google Scholar
• Razaghi, E., Rahimi-Movaghar, A., Amin-Esmaeili, M., Sahimi Izadian, E., & Baghestani, A. (2008). The study of prevalence of infectious diseases among injecting drug abusers and their correlated factors in Tehran in 2006–2007. Tehran, Iran: Iranian National Center for Addiction Studies.
   Google Scholar
• Roux, P., Lions, C., Michel, L., Mora, M., Daulouede, J. P., Marcellin, F., … Carrieri, P. M. (2014). Factors associated with HCV risk practices in methadone-maintained patients: The importance of considering the couple in prevention interventions. Substance Abuse Treatment, Prevention, and Policy, 9, 37. doi:10.1186/1747-597X-9-37
   PubMed Web of Science ®Google Scholar
• Ruta, S., & Cernescu, C. (2015). Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World Journal of Gastroenterology, 21, 10811–10823. doi:10.3748/wjg.v21.i38.10811
   PubMed Web of Science ®Google Scholar
• Sacks-Davis, R., Horyniak, D., Grebely, J., & Hellard, M. (2012). Behavioural interventions for preventing hepatitis C infection in people who inject drugs: A global systematic review. International Journal of Drug Policy, 23, 176–184. doi:10.1016/j.drugpo.2011.08.002
   PubMed Web of Science ®Google Scholar
• Sharhani, A., Mehrabi, Y., Noroozi, A., Nasirian, M., Higgs, P., Hajebi, A., … Shakiba, E. (2017). Hepatitis C virus seroprevalence and associated risk factors among male drug injectors in Kermanshah, Iran. Hepatitis Monthly, [Accepted manuscript]. doi:10.5812/hepatmon.58739
   Web of Science ®Google Scholar
• Smith, B. D., Jewett, A., Burt, R. D., Zibbell, J. E., Yartel, A. K., & Dinenno, E. (2013). “To share or not to share?” Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants. The Journal of Infectious Diseases, 208, 1934–1942. doi:10.1093/infdis/jit520
   PubMed Web of Science ®Google Scholar
• Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., … Garfein, R. S. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155, 645–653. doi:10.1093/aje/155.7.645
   PubMed Web of Science ®Google Scholar
• Wiessing, L., Ferri, M., Grady, B., Kantzanou, M., Sperle, I., Cullen, K. J., … Lazarus, J. V. (2014). Hepatitis C virus infection epidemiology among people who inject drugs in Europe: A systematic review of data for scaling up treatment and prevention. PloS One, 9, e103345. doi:10.1371/journal.pone.0103345
   PubMed Web of Science ®Google Scholar
• World Health Organisation. (2017). Global hepatitis report 2017. Geneva, Switzerland: Author.
   Google Scholar
• Zamani, S., Kihara, M., Gouya, M. M., Vazirian, M., Nassirimanesh, B., Ono-Kihara, M., … Ichikawa, S. (2006). High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. JAIDS Journal of Acquired Immune Deficiency Syndromes, 42, 342–346. doi:10.1097/01.qai.0000219785.81163.67
   PubMed Web of Science ®Google Scholar
• Zamani, S., Vazirian, M., Nassirimanesh, B., Razzaghi, E. M., Ono-Kihara, M., Ravari, S. M., … Kihara, M. (2010). Needle and syringe sharing practices among injecting drug users in Tehran: A comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS and Behavior, 14, 885–890. doi:10.1007/s10461-008-9404-2
   PubMed Web of Science ®Google Scholar
• Zule, W. A., Costenbader, E. C., Coomes, C. M., & Wechsberg, W. M. (2009). Effects of an HCV risk reduction motivational intervention on alcohol use, injection and sexual risk behaviors. American Journal of Public Health, 99, S180. doi:10.2105/AJPH.2007.126854
   PubMed Web of Science ®Google Scholar